Show simple item record

dc.contributor.authorGoodman, Shaun G.
dc.contributor.authorHuang, Wei
dc.contributor.authorYan, Andrew T.
dc.contributor.authorBudaj, Andrzej
dc.contributor.authorKennelly, Brian M.
dc.contributor.authorGore, Joel M.
dc.contributor.authorFox, Keith A. A.
dc.contributor.authorGoldberg, Robert J.
dc.contributor.authorAnderson, Frederick A.
dc.contributor.authorExpanded Global Registry of Acute Coronary Events (GRACE2) Investigators
dc.date2022-08-11T08:08:38.000
dc.date.accessioned2022-08-23T16:01:42Z
dc.date.available2022-08-23T16:01:42Z
dc.date.issued2009-08-22
dc.date.submitted2009-08-07
dc.identifier.issn1097-6744 (Electronic)
dc.identifier.pmid19619694
dc.identifier.urihttp://hdl.handle.net/20.500.14038/31191
dc.description.abstractBACKGROUND: The Global Registry of Acute Coronary Events (GRACE)-a prospective, multinational study of patients hospitalized with acute coronary syndromes (ACSs)-was designed to improve the quality of care for patients with an ACS. Expanded GRACE aims to test the feasibility of a simplified data collection tool and provision of quarterly feedback to index individual hospital management practices to an international reference cohort. METHODS: We describe the objectives; study design; study and data management; and the characteristics, management, and hospital outcomes of patients > or =18 years old enrolled with a presumptive diagnosis of ACS. RESULTS: From 2001 to 2007, 31,982 patients were enrolled at 184 hospitals in 25 countries; 30% were diagnosed with ST-segment elevation myocardial infarction, 31% with non-ST-segment myocardial infarction, 26% with unstable angina, and 12% with another cardiac/noncardiac final diagnosis. The median age was 65 (interquartile range 55-75) years; 24% were >75 years old, and 33% were women. In general, increases were observed over time across the spectrum of ACS (1) in the use in the first 24 hours and at discharge of aspirin, clopidogrel, beta-blockers, and angiotensin-converting enzyme inhibitors/receptor blockers; (2) in the use at discharge of statins; (3) in the early use of glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparin; and (4) in the use of cardiac catheterization and percutaneous coronary intervention. An increase in the use of primary percutaneous coronary intervention and a similar decrease in the use of fibrinolysis in ST-segment elevation myocardial infarction were also seen. CONCLUSIONS: Over the course of 7 years, general increases in the use of evidence-based therapies for ACS patients were observed in the expanded GRACE.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19619694&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.ahj.2009.06.003
dc.rightsCitation: Am Heart J. 2009 Aug;158(2):193-201.e1-5. <a href="http://dx.doi.org/10.1016/j.ahj.2009.06.003">Link to article on publisher's site</a>
dc.subjectAcute Coronary Syndrome
dc.subjectQuality of Health Care
dc.subjectEvidence-Based Medicine
dc.subjectCardiovascular Diseases
dc.subjectHealth Services Research
dc.titleThe expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes
dc.typeJournal Article
dc.source.journaltitleAmerican heart journal
dc.source.volume158
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_cphr/23
dc.identifier.contextkey928571
html.description.abstract<p>BACKGROUND: The Global Registry of Acute Coronary Events (GRACE)-a prospective, multinational study of patients hospitalized with acute coronary syndromes (ACSs)-was designed to improve the quality of care for patients with an ACS. Expanded GRACE aims to test the feasibility of a simplified data collection tool and provision of quarterly feedback to index individual hospital management practices to an international reference cohort.</p> <p>METHODS: We describe the objectives; study design; study and data management; and the characteristics, management, and hospital outcomes of patients > or =18 years old enrolled with a presumptive diagnosis of ACS.</p> <p>RESULTS: From 2001 to 2007, 31,982 patients were enrolled at 184 hospitals in 25 countries; 30% were diagnosed with ST-segment elevation myocardial infarction, 31% with non-ST-segment myocardial infarction, 26% with unstable angina, and 12% with another cardiac/noncardiac final diagnosis. The median age was 65 (interquartile range 55-75) years; 24% were >75 years old, and 33% were women. In general, increases were observed over time across the spectrum of ACS (1) in the use in the first 24 hours and at discharge of aspirin, clopidogrel, beta-blockers, and angiotensin-converting enzyme inhibitors/receptor blockers; (2) in the use at discharge of statins; (3) in the early use of glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparin; and (4) in the use of cardiac catheterization and percutaneous coronary intervention. An increase in the use of primary percutaneous coronary intervention and a similar decrease in the use of fibrinolysis in ST-segment elevation myocardial infarction were also seen.</p> <p>CONCLUSIONS: Over the course of 7 years, general increases in the use of evidence-based therapies for ACS patients were observed in the expanded GRACE.</p>
dc.identifier.submissionpathgsbs_cphr/23
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.contributor.departmentCenter for Outcomes Research
dc.source.pages193-201.e1-5
dc.contributor.studentWei Huang


This item appears in the following Collection(s)

Show simple item record